Now I have comprehensive calibration data. Let me synthesize and write the final review.

## Summary

This paper proposes a conformal prediction method for constructing lower prediction bounds (LPBs) for counterfactual survival times under general right-censoring. The core technical contribution is a reweighting scheme that transforms the coverage problem into weighted conformal inference via a Radon-Nikodym derivative, with doubly robust guarantees against model misspecification. The method is evaluated on synthetic data and a real clinical dataset of 541 lung cancer patients.

## Strengths

- **Principled reweighting scheme (impact +9.99):** The core technical idea — transforming the coverage problem into weighted conformal inference via the Radon-Nikodym derivative dℙ_X / dℙ_{X|W=w, e=1} — is a sound and non-obvious extension of Lei & Candès (2021) to the censored counterfactual setting. The normalization 𝔼[ω̂|𝒟_tr] = 1 is a sensible regularization.

- **Real clinical data evaluation (impact +9.76):** The application to 541 lung cancer patients with four radiochemotherapy regimens (Section 5.2) is a genuine strength. Showing that LPBs align with known clinical patterns (VMAT > IMRT, induction chemotherapy benefits, stage-dependent survival) gives practical credibility to the method.

- **Doubly robustness analysis (impact +9.35):** Theorem 4.2 characterizes when the method remains valid under misspecification of either the quantile estimator or the weight estimator. This doubly robust framing is a meaningful addition over the baselines.

- **Well-motivated problem (impact +0.10 — generic but accurate):** The paper correctly identifies that existing conformal methods for survival analysis provide PAC-type guarantees, and that extending weighted conformal prediction to counterfactual survival under general right-censoring is nontrivial.

## Weaknesses

### Fatal
None.

### Major

- **Overclaimed "exact" guarantee.** The paper uses "exact" 11+ times (abstract, introduction, contribution list, theorem description, discussion) to describe its coverage guarantee. However, Theorem 4.1 gives: ℙ(T(w) ≥ L̂) ≥ 1 − α − ½𝔼_{X∼ℙ_{X|W=w,e=1}}[|ω̂(X) − ω(X)|]. This is a bound with an unquantified error term that depends on weight estimation quality — it is not an exact guarantee. While the contrast with PAC-type methods is meaningful (the guarantee is conditional on training data rather than probabilistic over calibration draws), the repeated "exact" framing overstates what the theory delivers. Theorem 4.2 is asymptotic and makes no exact claim. The paper should reframe honestly: "approximate coverage with error controlled by weight estimation accuracy."

- **"Relative LPB" is never defined in the main text.** Every experimental figure (Figures 1–4) uses "Relative LPB" on the y-axis, and the paper states "the larger the relative LPB, the more informative it is" (line 236). Yet the metric is never formally defined in the main text — is it LPB divided by the oracle LPB? Normalized in some other way? This makes all quantitative comparisons of informativeness difficult to interpret. Without knowing what "Relative LPB" means, readers cannot evaluate the central experimental claim that the method produces less conservative LPBs.

### Minor

- **Equation (1) derivation from step (ii) to (iii) is opaque.** Step (ii) multiplies by 1/p(e=1|X,W=w) via the "tower property" without explanation. Step (iii) changes ℙ(T ≤ ...) to ℙ(T ≤ ..., e=1) and asserts an inequality direction. The paper defers to Lemma A.1 in the appendix. The main text should provide a sketch of why the inequality holds in the intended direction, as the entire method rests on this chain.

- **Figure 2 (multi-treatment) shows Ours with lower relative LPB but this is not discussed.** The caption states "the 'Ours' method consistently shows a lower relative LPB (closer to 1.0) compared to the other methods." Since the paper states "a higher relative LPB is better" (line 158), this means the method is *less* informative in multi-treatment settings. The paper's text (line 252) only says "the LPB varies across treatments but consistently satisfies the coverage guarantee," without addressing this tension.

- **LPB optimization over τ may affect coverage.** Line 162 states the procedure satisfies the coverage guarantee "for any τ ∈ (0,1)," and then τ is chosen per test point to maximize the LPB (τ^*(x) := argmax). The paper does not discuss whether this adaptive selection of τ based on calibration data affects the coverage guarantee.

- **No discussion of calibration set size limitations.** Algorithm 1 only uses data with W=w and e=1 for calibration. With high censoring rates or imbalanced treatment proportions, the effective calibration set per treatment can be very small. The paper acknowledges imbalanced treatment and censoring as challenges (Discussion) but does not analyze how small calibration samples affect the bound in Theorem 4.1.

- **The exchangeability/covariate-shift assumption is not stated explicitly.** The method implicitly relies on the covariate shift assumption being correct (via the Radon-Nikodym derivative formulation (3)), but the paper does not state what exchangeability condition is needed for the weighted conformal step to be valid.

### Trivial
None.

## Nice-to-Haves

- Provide explicit bounds or convergence rates for the 𝔼[|ω̂−ω|] term under specific conditions (e.g., if ω̂ is estimated via random forest or logistic regression with known rates).
- Include a simulation where the weight function is intentionally misspecified to demonstrate sensitivity of coverage to weight estimation quality.
- Report the proportion of trials where coverage falls below 1−α numerically (beyond box plots).

## Removed Points

These points from the input review are removed with justifications:

1. **Claim of undercoverage in Table 1** — Factually incorrect. Coverage rates are 0.958 (α=0.05, target 95%), 0.914 (α=0.10, target 90%), 0.872 (α=0.15, target 85%), 0.845 (α=0.20, target 80%). All are *above* the target. REMOVED.

2. **"No standard deviations reported"** — Box plots are shown across 50 trials (Figure 1) and 10 trials (Figures 2–4), which visually display the full distribution. Numerical quantification would be a nice addition but the box plots already convey variability. REMOVED as below trivial.

3. **Inequality direction error speculation based on missing Lemma A.1** — The reviewer claims the inequality in Equation (1) "may be reversed," but this depends on Lemma A.1 which exists in the original submission's appendix (stripped by the parser). Per review policy, the appendix is assumed to exist. The main-text opaqueness is noted as a Minor weakness; the speculation about an actual error is removed. REMOVED.

4. **Criticism that Theorem 4.2 is asymptotic** — The paper never claims Theorem 4.2 provides an exact guarantee; it is presented as a doubly robustness property. The contribution list (line 33) separately distinguishes "quantify the error from weight estimation" from "doubly robustness property." REMOVED.

5. **"Why PAC-type methods are sensitive to outliers"** — A reasonable question but not a weakness of the paper's method. The outlier experiment shows empirical advantage regardless of mechanism. REMOVED.

6. **Generic claims about missing synthetic data details** — The paper references Appendix C.1 for data generation details, which is standard practice. REMOVED as scope creep.

## Novel Insights

None beyond the paper's own contributions: the connection between weighted conformal inference and counterfactual survival prediction under censoring via the Radon-Nikodym derivative, and the doubly robust analysis, are the paper's own technical contributions.

## Suggestions

1. **Reframe the guarantee**: Replace "exact" with phrasing like "approximate coverage with error controlled by weight estimation quality" throughout the paper, including the abstract, introduction, and contribution list.

2. **Define "Relative LPB"** explicitly in the main text — this is essential for interpreting all experimental results.

3. **Add a brief sketch** of why the inequality in Equation (1) steps (ii)→(iii) holds in the intended direction, or provide the key conditioning argument from Lemma A.1.

4. **Address Figure 2 honestly** — discuss whether the method is less informative in multi-treatment settings and explain why.

5. **State the exchangeability/covariate-shift assumption** explicitly for the weighted conformal prediction step.

6. **Discuss adaptive τ selection** and whether it affects the coverage guarantee.

---

## Score and Decision

**Round 1 bracket:** 5.0–6.0, based on comparison with calibration anchors.

**Calibration anchors retrieved:**

| Path | Avg Score | Round | Itemized | Comparison |
|------|-----------|-------|----------|------------|
| aJ3tiX1Tu4 (Wasserstein-Regularized CP) | 6.67 | R1 | Yes | Higher-scoring paper with similar "approximate guarantee" theme; had more novel theory (Wasserstein decomposition) but also unfair comparison weaknesses (-10.00) and lack of formal guarantees (-6.20). Our paper has weaker novelty but stronger experimental validation (real clinical data). |
| j511LaqEeP (Non-Exchangeable Conformal Risk Control) | 6.00 | R2 | Yes | Similar profile: straightforward extension of existing ideas with weighting. Had incrementalism criticism (-9.99, -10.00) but accepted. Our paper has a more novel application domain. |
| Nfd7z9d6Bb (Probabilistic CP) | 6.00 | R1 | Yes | All 6s from 5 reviewers. Approximate conditional coverage. Our paper faces similar "only marginal improvement" concerns. |
| 4vPVBh3fhz (PAC Prediction Sets Under Label Shift) | 6.40 | R1 | Yes | PAC guarantees under shift. Had novelty concerns (-10.00). Our paper is comparable. |
| oP7arLOWix (Kernel-based Weighted CP Time-Series) | 6.00 | R1 | Yes | Similar weighted CP methodology. Had typos (-10.00) and missing algorithm details (-9.17). |
| RcNzwKrjTo (CP with Trust Scores) | 5.00 | R2 | Yes | Rejected — experiments didn't support claims (-9.87, -9.99). Our paper's experiments are substantially stronger (method clearly works) but has the undefined metric gap. |
| XgYPzNtz0s (Survival Analysis via Density Estimation) | 4.60 | R1 | Yes | Rejected — overclaimed contributions (-9.99), no practical usefulness shown (-10.00). Our paper is clearly above this. |
| Dtxc7mlKRg (Class-Conditional CP) | 4.60 | R2 | No | Lower band |
| 5lUdTogEL3 (Person Re-id) | 1.00 | R1 | No | Irrelevant topic |

**Narrowing:** Comparing scored items — our paper's two Major weaknesses (-9.17 overclaiming, -9.90 undefined metric) are comparable in magnitude to the decisive weaknesses in the 6.0-level papers (e.g., Non-Exchangeable CRC had -9.99, -10.00 for incrementalism). However, our paper also lacks the strong "proof/correctness" strength that anchored those papers (e.g., Non-Exchangeable CRC had +10.00 for proof correctness). Our strengths are empirical (+9.76 clinical data) and methodological (+9.99 reweighting scheme), which are somewhat weaker anchors than rigorous theory for this venue. The undefined "Relative LPB" metric is a more concrete presentation flaw than the incrementalism criticism levied at the 6.0 papers. Placing the paper just below the 6.0 Accept threshold is appropriate.

**Final Score: 5.5** — Borderline between borderline reject (4) and borderline accept (6). The core technical contribution is solid and the clinical evaluation is valuable, but the "exact" overclaiming must be corrected and the experimental metric must be defined for the claims to be evaluable.

MY FINAL SCORE: <score>5.5</score>
MY FINAL DECISION: <decision>Accept</decision>